Slide 1: Financial Year 2021 Results
FINANCIAL YEAR 2021 RESULTS.
Slide 2: FY21 Strategic Priorities
FY21 STRATEGIC PRIORITIES. During FY21, the Company continued its focus on a number of key strategic priorities: • Activating currently contracted agency groups to drive growth in Adslot Media trading fees; • Pursuing further market deployments for Symphony with existing agency clients; and • Mainta
Slide 3: FY21 Executive Summary
FY21 EXECUTIVE SUMMARY. • Adslot Media delivered its highest annual TTV* of $28.3M in FY21, an 82% increase on PCP • Adslot Media continued to sign MSAs, activate existing MSA partners, and implement new partner marketplaces • Symphony licence fees grew by 10%+ HoH • Symphony activated for Omnicom M
Slide 4: FY21 Financial Results
FY21 FINANCIAL RESULTS. Licence Fee Revs down 28%, Trading Fee Revs up 41% Group Revenue from Trading Licence Fee Trading Fee Revenue Continuing Technology Revenue Revenue Operations Revenue $9.623M $8.233M $6.434M $5.154M $1.281M -9% -16% -21% -28% +41% vs PCP
Slide 5: Operating Costs, EBITDA and NPAT
OPERATING COSTS, EBITDA AND NPAT. Operating EBITDA NPAT Costs Loss Loss $12.045M ($2.430M) ($6.281M) +3% -81% -62% vs PCP Note: FY20 EBITDA loss and NPAT loss includes impairment of Goodwill of $10.0M and once off provision for FY16 R&D Claim of $1.528M.
Slide 6: Compared to Adjusted FY20 EBITDA & NPAT
COMPARED TO ADJUSTED FY20 EBITDA & NPAT. Operating Adjusted Adjusted Costs EBITDA Loss NPAT Loss $12.045M ($2.430M) ($6.281M) +3% +103% +23% vs PCP Note: Adjusted EBITDA loss and Adjusted NPAT loss is after adding back impairment of Goodwill of $10.0M and once off provision for FY16 R&D Claim of $1.
Slide 7: Revenue Segments
Strategic Revenue REVENUE SEGMENTS. Licence Trading Three main revenue sources: Fee Fee Revenue Revenue • Licence Fees generated primarily from Symphony (but also from Adslot Media); • Trading Fees generated primarily from Adslot Media (but also from Symphony); and, Trading Technology • Service Fees
Slide 8: Licence Fee Revenue
LICENCE FEE REVENUE. -28% vs PCP Licence Fees $5.154M Licence Fees declined 28% on prior corresponding period (PCP) due to renegotiation of GroupM Symphony MSA including: • Temporary fee reductions and market tier caps in the half year to 31 December 2020 due to COVID-19; • Reduction in non-market r
Slide 9: Trading Fee Revenue
TRADING FEE REVENUE. +41% vs PCP Trading Fees $1.281M • Note: Trading Fee revenues are invoiced and recognised in the Company accounts in the month(s) in which the advertising activity is published, and on a pro-rata basis where activity falls over multiple months. • The Total Transaction Value, whi
Slide 10: Trading Technology Revenue
TRADING TECHNOLOGY REVENUE. -21% vs PCP Trading Technology $6.434M • Trading Technology revenue (Licence Fees and Trading Fees combined) declined by 21% on prior corresponding period (PCP). • The decrease in Trading Technology revenue was driven by a reduction of $2.053M (-28%) in Licence Fees and a
Slide 11: Services Revenue
SERVICES REVENUE. +7% vs PCP Services $1.791M • The majority of services revenue comes from the Company’s Webfirm services division ($1.498M). • Non-Strategic Services revenue of $1.791M represents a 7% increase on PCP.
Slide 12: Operating Costs
OPERATING COSTS. +3% vs PCP Operating Costs $12.045M • Total Operating costs of $12.045M were 3% higher on prior corresponding period (PCP). • Operating Costs are Total Expenses excluding Depreciation and Amortisation, interest expenses, once off R&D Provision, goodwill impairment and taxes.
Slide 13: Operating Costs
OPERATING COSTS. • Total Operating costs of $12.04m for the year were 3% higher on PCP. • Operating Costs are Total Expenses excluding depreciation and amortisation, interest expenses, once off R&D provision, intangible impairment and Taxes. • Employee benefits expense were flat on PCP ($7.63m). • C
Slide 14: EBITDA
EBITDA. -81% vs PCP EBITDA Loss ($2.430M) • Substantial improvement in EBITDA Loss. Note: FY20 includes once off impairment of Goodwill of $10.0M and once off provision for FY16 R&D Claim of $1.528M. EBITDA loss after excluding those once off items was $1.197M.
Slide 15: Compared to FY20 Adjusted EBITDA
COMPARED TO FY20 ADJUSTED EBITDA. +103% vs PCP Adjusted EBITDA Loss ($2.430M) • Increase in Adjusted EBITDA loss. Note: Adjusted EBITDA is after adding back impairment of Goodwill of $10.0M and once off provision for FY16 R&D Claim of $1.528M to the Unadjusted EBITDA loss ($12.725M)
Slide 16: NPAT
NPAT. -62% vs PCP NPAT Loss ($6.281M) • NPAT Loss decreased by 62% on PCP to $6.281M. Note: FY20 includes once off impairment of Goodwill of $10.0M and once off provision for FY16 R&D Claim of $1.528M. NPAT loss after excluding those once off items was $5.090M.
Slide 17: Compared to Adjusted FY20 NPAT
COMPARED TO ADJUSTED FY20 NPAT. 23% vs PCP Adjusted NPAT Loss ($6.281M) • Adjusted NPAT Loss increased by 23% on PCP to $6.281M Note: Adjusted NPAT loss is after adding back impairment of Goodwill of $10.0M and once off provision for FY16 R&D Claim of $1.528M to the Unadjusted NPAT loss ($16.618M) i
Slide 18: Cash Receipts, Operating Cash Flows and Year End Cash Position
CASH RECEIPTS, OPERATING CASH FLOWS AND YEAR END CASH POSITION. Net Cash Receipts Operating Cash Cash Outflows $6.827M $ 13.556M ($0.293M) -30% -91% +11% vs PCP
Slide 19: Strategic Priorities for the Coming Year
STRATEGIC PRIORITIES FOR THE COMING YEAR. During FY2022, the Company will continue its focus on the following strategic priorities: • Scale trading on Adslot Media partner marketplaces in the US and UK; • Further activate and scale trading from contracted agency groups; • Explore strategic partnersh
Slide 20: Disclaimer
DISCLAIMER. The information contained in this presentation is given in good faith and has been prepared from information believed to be accurate and reliable. The information presented does not take into account your individual financial circumstances and it is not designed to be a substitute for sp
Slide 21: Thank You
THANK YOU. Please direct any questions to: investor.relations@adslot.com